MyFinsight
Home
Blog
About
Contact
Download
Download image
Net proceeds from
july 2025 offering
$4,281,300
Net proceeds from
february 2025 offering
$908,627
Net proceeds from
january 2025 offering
$804,346
Net proceeds from
atm offering
$458,614
Maturities of short-term
investments
$1,708,000
Proceeds from exercise of
pre-funded warrants
$2,804
Net cash provided by
financing activities
$6,437,691
Net cash provided by
(used in) investing...
$254,916
Effect of exchange rate
changes on cash
$7,127
Canceled cashflow
$18,000
Canceled cashflow
$1,453,084
Change in cash and cash
equivalents
-$149,288
Canceled cashflow
$6,699,734
Accounts payable and
accrued liabilities
$491,083
Share-based compensation
under equity...
$279,873
Change in inventory
reserve
$251,677
Amortization of capitalized
share-based payments
$176,471
Depreciation
$43,324
Amortization
$39,548
Accrued interest, net
-$11,635
Shares withheld for net
share settlement of...
$18,000
Purchase of short-term
investments
$1,235,000
Purchases of fixed assets
$139,881
Capitalization of patents
$55,533
Acquisition of intangibles
$22,670
Net cash used in
operating activities
-$6,849,022
Canceled cashflow
$1,293,611
Net loss
-$7,368,325
Inventory
$465,837
Change in fair value of
derivative liabilities
$266,089
Accounts receivable
$22,896
Prepaid and other assets
$19,486
Back
Back
Cash Flow
source: myfinsight.com
60 DEGREES PHARMACEUTICALS, INC. (SXTPW)
60 DEGREES PHARMACEUTICALS, INC. (SXTPW)